ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 78,337 | 50,847 | 24,230 | 15,681 | -18,522 |
| Depreciation Amortization | 91,417 | 68,804 | 46,172 | 22,891 | 81,330 |
| Income taxes - deferred | 14,237 | 11,881 | -6,919 | -3,383 | -21,913 |
| Accounts receivable | -58,530 | -30,674 | -3,709 | 1,782 | -21,087 |
| Other Working Capital | -7,123 | 19,730 | 37,565 | 1,329 | -11,185 |
| Other Operating Activity | 66,887 | 34,270 | 13,464 | -3,309 | 55,394 |
| Operating Cash Flow | $185,225 | $154,858 | $110,803 | $34,991 | $64,017 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13,835 | -12,591 | -6,488 | -2,474 | -2,722 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -401,280 |
| Purchase Sale Intangibles | -20,486 | -20,327 | -20,267 | -17,372 | -717 |
| Other Investing Activity | -20,486 | -20,327 | -20,267 | -17,372 | -717 |
| Investing Cash Flow | $-34,321 | $-32,918 | $-26,755 | $-19,846 | $-404,719 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | -4,062 | -2,031 | 316,250 |
| Debt Issued | N/A | 0 | N/A | N/A | 325,000 |
| Common Stock Issued | 13,604 | 13,566 | 3,776 | 2,534 | 6,488 |
| Common Stock Repurchased | -12,209 | -11,598 | -10,554 | -10,003 | -10,959 |
| Dividend Paid | -1,157 | -1,157 | -813 | -406 | -1,625 |
| Other Financing Activity | -10,182 | -6,119 | 0 | 0 | -370,209 |
| Financing Cash Flow | $-9,944 | $-5,308 | $-11,653 | $-9,906 | $264,945 |
| Exchange Rate Effect | -233 | 1,120 | 544 | -297 | -470 |
| Beginning Cash Position | 144,894 | 144,894 | 144,894 | 144,894 | 221,121 |
| End Cash Position | 285,621 | 262,646 | 217,833 | 149,836 | 144,894 |
| Net Cash Flow | $140,727 | $117,752 | $72,939 | $4,942 | $-76,227 |
| Free Cash Flow | |||||
| Operating Cash Flow | 185,225 | 154,858 | 110,803 | 34,991 | 64,017 |
| Capital Expenditure | -13,835 | -12,591 | -6,488 | -2,474 | -16,236 |
| Free Cash Flow | 171,390 | 142,267 | 104,315 | 32,517 | 47,781 |